Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mach7 Technologies.
RELATED STOCKHEAD STORIES
Tech
ASX tech stocks: Dropsuite (ASX:DSE) climbs after reporting 15% increase in annual recurring revenue
Health & Biotech
ASX health stocks: AusCann (ASX:AC8) up 5pc after asking for approval of cannabis-based canine drug
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX health stocks today: AdAlta (ASX:1AD) leads after successful Phase I study
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues
Health & Biotech
ScoPo’s Powerplays: Biogen drama, M&A action, and profit-taking coloured the week in healthcare
Experts
ScoPo’s Powerplays: Hearing tech, medical devices to ride out choppy market
Experts
ScoPo’s Powerplays: Budget boost and inflation fears meet head on
Tech
$118m and a ‘Patent Box’: Here are the AI stocks looking to make the most of the Budget
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
Experts
ScoPo’s Powerplays: A disappointing week for healthcare investors
Experts
ScoPo’s powerplays: Look to Mach7, Volpara and IMEXHS as quarterly reports near
Experts
ScoPo’s powerplays: His Mach7 pick paid off – will Impedimed rise as well?
Experts
Scopo’s powerplays: Healthcare steadies, and Mach7 ‘looks really interesting’
Experts
ScoPo’s health powerplays: What to look for this earnings season
Health & Biotech
